Merger Creates World-Class CRO With Decades of Clinical Trials Support; Strengths in Oncology, Dermatology, Nephrology, and Medical Device Trials BOSTON, MA and SAN DIEGO, CA Jul 6, 2006, IT&E International Group, Inc. (OTC BB:ITER.OB), a life sciences service organization and full-service clinical research organization (“CRO”), today announced that it has entered into an Agreement and
San Diego, Sequenom, Inc. (Nasdaq:SQNM) today announced that its stockholders have approved the Company’s private placement financing to raise gross proceeds of $33 million through commitments from ComVest Investment Partners II LLC (“Comvest”), Pequot Private Equity Fund IV, L.P. (“Pequot”), LB I Group, Inc. (an affiliate of Lehman Brothers), and Siemens Venture Capital GmbH. The
Las Vegas, Nevada – Allegiant Travel a ComVest portfolio company, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The shares of common stock to be sold in the offering are expected to be
Salt Lake City, UT – May 9, 2006 – UCN, Inc. (OTC.BB:UCNN), announced today that the Company entered into a revolving credit and term loan agreement with ComVest Capital on May 5, 2006. Under the terms of the agreement ComVest has agreed to loan up to $7.5 million under a revolving credit note and $4.5
IT&E International Group, Inc. Announces Appointment of Interim Chief Executive Officer Tuesday May 2, 8:10 pm ET SAN DIEGO, CA, May 2, 2006 IT&E International Group, Inc. today announced that it is progressing with its strategy to grow organically and by acquisition in the CRO sector. To this end, it is pleased to announce that
Milwaukee, WI, April 12, 2006— On the strength of new sales to one of the world’s largest automotive manufacturers, to a leading appliance manufacturer, and to a large regional department-store chain, Catalyst completed its first quarter of 2006 with growth that was above expectations in license sales, services business, and overall profitability. These first quarter
SAN DIEGO, April 3 2006, Sequenom, Inc. (Nasdaq: SQNM) today announced that the amount of its previously announced private placement of common stock has been increased by $3 million to a total of $33 million. Siemens Venture Capital GmbH has agreed to join the previously announced investors ComVest Investment Partners II LLC, Pequot Private Equity
SAN DIEGO Sequenom Inc., a maker of biotechnology research equipment, said Tuesday a group of investors has agreed to buy stock and warrants of the company for $30 million, which Sequenom will use for working capital needs. Sequenon said it received the investment commitments from ComVest Investment Partners II LLC, Pequot Private Equity Fund IV
SAN DIEGO, CA, IT&E International Group (ITER), today announced that Gene Resnick, MD has been appointed Vice President, Chief Medical Officer as the company joins with Millennix, Inc. to form the next generation CRO (Clinical Research Organization). Peter Sollenne, IT&E International Group CEO, said, “Dr. Resnick is a recognized expert in drug development, oncology, and
CorVu Corporation (CRVU), the innovative provider of Performance Management software solutions, has partnered with ExecuEdge LLC. This partnership brings additional strength to the CorVu solution by navigating companies through the entire strategy life cycle. CorVu software solutions, together with consulting services from ExecuEdge, will help organizations integrate all disciplines critical for strategy formulation and execution.
